The Flavonoid Quercetin Ameliorates Liver Inflammation and Fibrosis by Regulating Hepatic Macrophages Activation and Polarization in Mice
Open accessAbstract
At present, there are no effective antifibrotic drugs for patients with chronic liver disease; hence, the development of antifibrotic therapies is urgently needed. Here, we performed an experimental and translational study to investigate the potential and underlying mechanism of quercetin treatment in liver fibrosis, mainly focusing on the impact of quercetin on macrophages activation and polarization. BALB/c mice were induced liver fibrosis by carbon tetrachloride (CCl4) for 8 weeks and concomitantly treated with quercetin (50 mg/kg) or vehicle by daily gavage. Liver inflammation, fibrosis, and hepatic stellate cells (HSCs) activation were examined. Moreover, massive macrophages accumulation, M1 macrophages and their related markers, such as tumor necrosis factor (TNF)-, interleukin (IL)-1β, IL-6 and monocyte chemotactic protein 1(MCP-1) in livers were analyzed. In vitro, we used Raw 264.7 cells to examine the effect of quercetin on M1-polarized macrophages activation. Our results showed that quercetin dramatically ameliorated liver inflammation, fibrosis, and inhibited HSCs activation. These results were attributed to the reductive recruitment of macrophages (F4/80+ and CD68+) into the liver in quercetin-treated fibrotic mice confirmed by immunostaining and expression levels of marker molecules. Importantly, quercetin strongly inhibited M1 polarization and M1-related inflammatory cytokines in fibrotic livers when compared with vehicle-treated mice. In vitro, studies further revealed that quercetin efficiently inhibited macrophages activation and M1 polarization, as well as decreased the mRNA expression of M1 macrophage markers such as TNF-, IL-1β, IL-6 and nitric oxide synthase 2 (NOS2). Mechanistically, the inhibition of M1 macrophages by quercetin was associated with the decrease levels of Notch1 expression on macrophages both in vivo and in vitro. Taken together, our data indicated that quercetin attenuated CCl4-induced liver inflammation and fibrosis in mice through inhibiting macrophages infiltration and modulating M1 macrophages polarization via targeting Notch1 pathway. Hence, quercetin holds promise as potential therapeutic agent for human fibrotic liver disease.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Exposure to supernatant from VIS cells induced macrophage activation marked by an M1-like polarization profile, CD86 upregulation, and signs of secondary macrophage senescence detected by SA-β-gal staining and senescence-typical gene expression.
“it was demonstrated that exposure to the supernatant of VIS cells induced macrophage activation that was marked by an M1-like polarization profile79,89, CD86 upregulation and signs of secondary macrophage senescence as detected by SA-β-gal staining and senescence-typical gene expression.”
From COVID-19 and cellular senescence (2023) · cites this paper as [89]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335 · see citing works
Macrophage biology in development, homeostasis and disease
Wynn, T. A., Chawla, A., & Pollard, J. W. (2013) · Nature · doi:10.1038/nature12034 · Cited by 4,684 · cited 1× · see citing works
“It has revealed that macrophage differentiation and activation is subjected to tight control by several mechanisms, including signaling molecules, transcription factors, epigenetic mechanisms, and posttranscriptional regulators (Lawrence and Natoli, 2011; Wynn et al., 2013; Xu et al., 2015b).”
BackgroundMacrophages in Tissue Repair, Regeneration, and Fibrosis
Wynn, T. A., & Vannella, K. M. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.015 · Cited by 4,481 · see citing works
Mechanisms of hepatic stellate cell activation
Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909 · see citing works
Mechanisms of Hepatic Fibrogenesis
Friedman, S. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.003 · Cited by 2,640 · see citing works
Transcriptional regulation of macrophage polarization: enabling diversity with identity
Lawrence, T., & Natoli, G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3088 · Cited by 2,284 · see citing works
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., & Iredale, J. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522675 · Cited by 1,649 · see citing works
Classification of chronic viral hepatitis: a need for reassessment
Scheuer, P. J. (1991) · Journal of Hepatology · doi:10.1016/0168-8278(91)90084-o · Cited by 1,588 · see citing works
Liver fibrosis and repair: Immune regulation of wound healing in a solid organ
Pellicoro, A., Ramachandran, P., Iredale, J. P., & Fallowfield, J. A. (2014) · Nature Reviews Immunology · doi:10.1038/nri3623 · Cited by 1,310 · see citing works
Macrophage heterogeneity in liver injury and fibrosis
Tacke, F., & Zimmermann, H. W. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.025 · Cited by 1,061 · see citing works
Targeting hepatic macrophages to treat liver diseases
Tacke, F. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.02.026 · Cited by 1,003 · see citing works
Hepatic inflammation and fibrosis: Functional links and key pathways
Seki, E., & Schwabe, R. F. (2015) · Hepatology · doi:10.1002/hep.27332 · Cited by 972 · see citing works
The flavonoid quercetin in disease prevention and therapy: Facts and fancies
Russo, M., Spagnuolo, C., Tedesco, I., Bilotto, S., & Russo, G. L. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.08.010 · Cited by 700 · see citing works
Pradere, J.-P., Kluwe, J., De Minicis, S., Jiao, J.-J., Gwak, G.-Y., Dapito, D. H., Jang, M.-K., Guenther, N. D., Mederacke, I., Friedman, R., et al. (2013) · Hepatology · doi:10.1002/hep.26429 · Cited by 613 · see citing works
Wan, J., Benkdane, M., Teixeira-Clerc, F., Bonnafous, S., Louvet, A., Lafdil, F., Pecker, F., Tran, A., Gual, P., Mallat, A., et al. (2014) · Hepatology · doi:10.1002/hep.26607 · Cited by 558 · see citing works
Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2
Miura, K., Yang, L., van Rooijen, N., Ohnishi, H., & Seki, E. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00365.2011 · Cited by 503 · see citing works
Macrophage Plasticity and Polarization in Liver Homeostasis and Pathology
Sica, A., Invernizzi, P., & Mantovani, A. (2014) · Hepatology · doi:10.1002/hep.26754 · Cited by 422 · see citing works
Dong, J., Zhang, X., Zhang, L., Bian, H., Xu, N., Bao, B., & Liu, J. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m038786 · Cited by 295 · see citing works
Wu, L., Zhang, Q., Mo, W., Feng, J., Li, S., Li, J., Liu, T., Xu, S., Wang, W., Lu, X., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09673-5 · Cited by 272 · see citing works
NOTCH reprograms mitochondrial metabolism for proinflammatory macrophage activation
Xu, J., Chi, F., Guo, T., Punj, V., Lee, W. N. P., French, S. W., & Tsukamoto, H. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76468 · Cited by 241 · see citing works
Notch signaling is activated by TLR stimulation and regulates macrophage functions
Palaga, T., Buranaruk, C., Rengpipat, S., Fauq, A. H., Golde, T. E., Kaufmann, S. H. E., & Osborne, B. A. (2007) · European Journal of Immunology · doi:10.1002/eji.200636999 · Cited by 233 · see citing works
Quercetin inhibits inducible ICAM-1 expression in human endothelial cells through the JNK pathway
Kobuchi, H., Roy, S., Sen, C. K., Nguyen, H. G., & Packer, L. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.277.3.c403 · Cited by 197 · see citing works
Quercetin Treatment Ameliorates Inflammation and Fibrosis in Mice with Nonalcoholic Steatohepatitis3
Marcolin, É., San‐Miguel, B., Vallejo, D., Tieppo, J., Marroni, N. P., González‐Gallego, J., & Tuñón, M. J. (2012) · Journal of Nutrition · doi:10.3945/jn.112.165274 · Cited by 177 · see citing works
Tosello‐Trampont, A., Krueger, P., Narayanan, S., Landes, S. G., Leitinger, N., & Hahn, Y. S. (2016) · Hepatology · doi:10.1002/hep.28389 · Cited by 142 · see citing works
Kim, Y., & Park, W. (2016) · Molecules · doi:10.3390/molecules21040450 · Cited by 124 · see citing works
Overman, A., Chuang, C.-C., & McIntosh, M. (2011) · International Journal of Obesity · doi:10.1038/ijo.2010.272 · Cited by 112 · see citing works
Bansal, R., van Baarlen, J., Storm, G., & Prakash, J. (2015) · Scientific Reports · doi:10.1038/srep18272 · Cited by 107 · see citing works
Hernández‐Ortega, L. D., Alcántar‐Díaz, B. E., Ruiz-Corro, L., Sandoval-Rodriguez, A. S., Bueno‐Topete, M. R., Armendáriz‐Borunda, J., & Salazar-Montes, A. M. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07262.x · Cited by 106 · see citing works
Notch Regulates Macrophage-Mediated Inflammation in Diabetic Wound Healing
Kimball, A., Joshi, A., Boniakowski, A. E., Schaller, M. A., Chung, J., Allen, R., Bermick, J., Carson, W. F., Henke, P. K., Maillard, I. P., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00635 · Cited by 101 · see citing works
Beljaars, L., Schippers, M., Reker‐Smit, C., Martínez, F. O., Helming, L., Poelstra, K., & Melgert, B. N. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00430 · Cited by 97 · see citing works
Wilhelm, A., Aldridge, V., Haldar, D., Naylor, A. J., Weston, C. J., Hedegaard, D. L., Garg, A., Fear, J., Reynolds, G. M., Croft, A. P., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-308325 · Cited by 92 · see citing works
Svendsen, P., Graversen, J. H., Etzerodt, A., Hager, H., Røge, R., Grønbæk, H., Christensen, E. I., Møller, H. J., Vilstrup, H., & Moestrup, S. K. (2017) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2016.11.004 · Cited by 84 · see citing works
Wijesundera, K. K., Izawa, T., Tennakoon, A. H., Murakami, H., Golbar, H. M., Katou-Ichikawa, C., Tanaka, M., Kuwamura, M., & Yamate, J. (2014) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2014.04.003 · Cited by 77 · see citing works
Li, X., Jin, Q., Yao, Q., Xu, B., Li, Z., & Tu, C. (2016) · Toxicology Letters · doi:10.1016/j.toxlet.2016.09.002 · Cited by 75 · see citing works
Self-citationIRF5 governs liver macrophage activation that promotes hepatic fibrosis in mice and humans
Alzaïd, F., Lagadec, F., Albuquerque, M., Ballaire, R., Orliaguet, L., Hainault, I., Blugeon, C., Lemoine, S., Lehuen, A., Saliba, D. G., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.88689 · Cited by 66 · see citing works
Horrillo, R., Planagumà, A., González‐Périz, A., Ferré, N., Titos, E., Miquel, R., López‐Parra, M., Masferrer, J. L., Arroyo, V., & Clària, J. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.128264 · Cited by 56 · see citing works
Li, X., Liu, H., Yao, Q., Xu, B., Zhang, S., & Tu, C. (2015) · Inflammation · doi:10.1007/s10753-015-0227-9 · Cited by 51 · see citing works
Self-citationLi, X., Jin, Q., Yao, Q., Zhou, Y., Zou, Y., Li, Z., Zhang, S., & Tu, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00801 · Cited by 48 · see citing works
Self-citationLabonte, A. C., Sung, S. J., Jennelle, L. T., Dandekar, A. P., & Hahn, Y. S. (2016) · Hepatology · doi:10.1002/hep.28873 · Cited by 35 · see citing works
Li, X., Yao, Q., Liu, H., Jin, Q., Xu, B., Zhang, S., & Tu, C. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13158 · Cited by 35 · see citing works
Self-citationOhtsuki, T., Kimura, K., Tokunaga, Y., Tsukiyama–Kohara, K., Tateno, C., Hayashi, Y. K., Hishima, T., & Kohara, M. (2015) · Journal of Virology · doi:10.1128/jvi.02293-15 · Cited by 26 · see citing works
Notch signaling and M1 macrophage activation in obesity-alcohol synergism
Xu, J., Chi, F., & Tsukamoto, H. (2015) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2015.05.016 · Cited by 25 · see citing works
Dual Notch signaling in proinflammatory macrophage activation
Eun, H. S., & Jeong, W. (2015) · Hepatology · doi:10.1002/hep.28386 · Cited by 8 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Macrophage Polarization and Its Role in Liver Disease
Wang, C., Ma, C., Gong, L., Guo, Y., Fu, K., Zhang, Y., Zhou, H., & Li, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.803037 · Cited by 583 · see citing works
Virus-induced senescence is a driver and therapeutic target in COVID-19
Lee, S., Yu, Y., Trimpert, J., Benthani, F., Mairhofer, M., Richter-Pechanska, P., Wyler, E., Belenki, D., Kaltenbrunner, S., Pammer, M., et al. (2021) · Nature · doi:10.1038/s41586-021-03995-1 · Cited by 350 · see citing works
Hu, Y. H., Gui, Z., Zhou, Y., Xia, L., Lin, K., & Xu, Y. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.09.024 · Cited by 291 · see citing works
Wang, Y., Li, C., Wan, Y., Qi, M., Chen, Q., Sun, Y. L., Sun, X., Fang, J., Fu, L., Xu, L. H., et al. (2021) · Small · doi:10.1002/smll.202101505 · Cited by 228 · see citing works
Teng, H., Zheng, Y., Cao, H., Huang, Q., Xiao, J., & Chen, L. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1947772 · Cited by 206 · see citing works
Hepatic macrophages: Key players in the development and progression of liver fibrosis
Cheng, D., Chai, J., Wang, H., Fu, L., Peng, S., & Ni, X. (2021) · Liver International · doi:10.1111/liv.14940 · Cited by 188 · see citing works
COVID-19 and cellular senescence
Schmitt, C. A., Tchkonia, T., Niedernhofer, L. J., Robbins, P. D., Kirkland, J. L., & Lee, S. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00785-2 · Cited by 153 · see citing works
Zhao, X., Wang, J., Deng, Y., Liao, L., Zhou, M., Peng, C. Y., & Li, Y. (2021) · Phytotherapy Research · doi:10.1002/ptr.7104 · Cited by 126 · see citing works
Molecular and Cellular Mechanisms of Propolis and Its Polyphenolic Compounds against Cancer
Oršolić, N., & Jembrek, M. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810479 · Cited by 132 · see citing works
Celastrol exerts anti‐inflammatory effect in liver fibrosis via activation of AMPK‐SIRT3 signalling
Wang, Y., Li, M., Gu, J., Chen, C., Duanmu, J., Miao, J., Yao, W., Tao, J., Tu, M., Xiong, B., et al. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14805 · Cited by 106 · see citing works
Deletion of SA β‐Gal+ cells using senolytics improves muscle regeneration in old mice
Dungan, C. M., Murach, K. A., Zdunek, C. J., Tang, Z. J., Nolt, G. L., Brightwell, C. R., Hettinger, Z. R., Englund, D. A., Liu, Z., Fry, C. S., et al. (2021) · Aging Cell · doi:10.1111/acel.13528 · Cited by 105 · see citing works
Focus on the high therapeutic potentials of quercetin and its derivatives
Septembre‐Malaterre, A., Boumendjel, A., Seteyen, A.-L. S., Boina, C., Gasque, P., Guiraud, P., & Sélambarom, J. (2022) · Phytomedicine Plus · doi:10.1016/j.phyplu.2022.100220 · Cited by 104 · see citing works
Luteolin: A flavone with myriads of bioactivities and food applications
Bangar, S. P., Kajla, P., Chaudhary, V., Sharma, N. N., & Özoğul, F. (2023) · Food Bioscience · doi:10.1016/j.fbio.2023.102366 · Cited by 101 · see citing works
Abdu, S. B. S., Juaid, N., Amin, A., Moulay, M., & Miled, N. (2022) · Molecules · doi:10.3390/molecules27228082 · Cited by 98 · see citing works
Antitumor Effects of Quercetin in Hepatocarcinoma In Vitro and In Vivo Models: A Systematic Review
Fernández‐Palanca, P., Fondevila, F., Méndez‐Blanco, C., Tuñón, M. J., González‐Gallego, J., & Mauriz, J. L. (2019) · Nutrients · doi:10.3390/nu11122875 · Cited by 93 · see citing works
Wu, K., Liu, Y.-Y., Shao, S., Song, W., Chen, X.-H., Dong, Y.-T., & Zhang, Y.-M. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.06.003 · Cited by 83 · see citing works
Flavonoids-mediated SIRT1 signaling activation in hepatic disorders
Sayed, A. M. M., Hassanein, E. H. M., Salem, S. H., Hussein, O. E., & Mahmoud, A. M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118173 · Cited by 75 · see citing works
Inhibitory Effect of Quercetin on Propionibacterium acnes-induced Skin Inflammation
Lim, H.-J., Kang, S.-H., Song, Y.-J., Jeon, Y., & Jin, J. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107557 · Cited by 75 · see citing works
Yao, Q., Li, S., Li, X., Wang, F., & Tu, C. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00071 · Cited by 71 · see citing works
Self-citationFunction of TREM1 and TREM2 in Liver-Related Diseases
Sun, H., Feng, J., & Tang, L. (2020) · Cells · doi:10.3390/cells9122626 · Cited by 71 · see citing works
Flavonoids: Broad Spectrum Agents on Chronic Inflammation
Lim, H. A., Heo, M. Y., & Kim, H. P. (2019) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2019.034 · Cited by 71 · see citing works
Targeting monocytes/macrophages in fibrosis and cancer diseases: Therapeutic approaches
Conte, E. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108031 · Cited by 58 · see citing works
The Potential Application of Chinese Medicine in Liver Diseases: A New Opportunity
Fu, K., Wang, C., Ma, C., Zhou, H., & Li, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.771459 · Cited by 53 · see citing works
Pan, X., Ma, X., Jiang, Y., Wen, J., Yang, L., Chen, D., Cao, X., & Peng, C. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/7171498 · Cited by 52 · see citing works
The role of phytochemicals in sepsis: A mechanistic and therapeutic perspective
Alikiaii, B., Bagherniya, M., Askari, G., Johnston, T. P., & Sahebkar, A. (2020) · BioFactors · doi:10.1002/biof.1694 · Cited by 52 · see citing works
Wu, B., Wang, R., Li, S., Wang, Y., Song, F., Gu, Y., & Yuan, Y. (2019) · Pharmacological Reports · doi:10.1016/j.pharep.2019.01.008 · Cited by 49 · see citing works
Quayum, S. T., Esha, N. J. I., Siraji, S., Abbad, S. S. A., Alsunaidi, Z. H. A., Almatarneh, M. H., Rahman, S., Alodhayb, A. N., Alibrahim, K. A., Kawsar, S. M. A., et al. (2023) · MethodsX · doi:10.1016/j.mex.2023.102537 · Cited by 46 · see citing works
Fang, J., & Liang, W. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.07.059 · Cited by 42 · see citing works
Protective and therapeutic effects of nanoliposomal quercetin on acute liver injury in rats
Liu, X., Zhang, Y., Liu, L., Pan, Y., Hu, Y., Pu, Y., & Liao, M. (2020) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-020-0388-5 · Cited by 44 · see citing works
Zima, V., Radilová, K., Kožíšek, M., Albiñana, C. B., Karlukova, E., Brynda, J., Fanfrlík, J., Flieger, M., Hodek, J., Weber, J., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112754 · Cited by 43 · see citing works
Li, X., Yao, Q., Huang, J., Jin, Q., Xu, B., Chen, F., & Tu, C. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01089 · Cited by 40 · see citing works
Self-citationWang, T., Liu, L., Deng, J., Jiang, Y., Yan, X., & Liu, W. (2023) · Food & Function · doi:10.1039/d2fo03509j · Cited by 39 · see citing works
Wang, Y., Huang, S., Kong, W., Wu, C., Zeng, T., Xie, S., Chen, Q., Kuang, S., Zheng, R., Wang, F., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155016 · Cited by 36 · see citing works
Crespo, I., Fernández‐Palanca, P., San‐Miguel, B., Alvarez, M., González‐Gallego, J., & Tuñón, M. J. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15398 · Cited by 36 · see citing works
RetractedFang, P., Liang, J., Jiang, X., Fang, X., Wu, M., Wei, X., Yang, W., Hou, W., & Zhang, Q. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00608 · Cited by 34 · see citing works
Plant‐derived flavonoids are a potential source of drugs for the treatment of liver fibrosis
Zhao, B., Liu, K., Liu, X., Li, Q., Li, Z., Xi, J., Xie, F., & Li, X. (2024) · Phytotherapy Research · doi:10.1002/ptr.8193 · Cited by 32 · see citing works
Self-citationCatelan, T. B. S., Radai, J. A. S., Leitão, M. M., Branquinho, L. S., Vasconcelos, P. C. D. P., Vieira, S. C. H., Kassuya, C. A. L., & Cardoso, C. A. L. (2018) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2018.08.015 · Cited by 31 · see citing works
Sun, Z., Xiong, H., Lou, T., Liu, W., Xu, Y., Yu, S., Wang, H., Liu, W., Yang, L., Zhou, C., et al. (2023) · Gels · doi:10.3390/gels9050381 · Cited by 29 · see citing works
Elshawi, O. E., El‐Nashar, H. A. S., El‐Rahman, S. S. A., Eldahshan, O. A., & Singab, A. N. B. (2022) · International Journal of Radiation Biology · doi:10.1080/09553002.2022.2087926 · Cited by 29 · see citing works
Polyphenol-based targeted therapy for oral submucous fibrosis
Mehta, C. H., Paliwal, S., Muttigi, M. S., Seetharam, R. N., Prasad, A. S. B., Nayak, Y., Acharya, S., & Nayak, U. Y. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01212-1 · Cited by 28 · see citing works
Quercetin reduces tendon adhesion in rat through suppression of oxidative stress
Liang, Y., Xu, K., Zhang, P., Zhang, J., Chen, P., He, J., Fang, Y., Zhou, Y., Wang, J., & Bai, J. (2020) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-020-03618-2 · Cited by 27 · see citing works
Chen, Q., Bao, L., Lv, L., Xie, F., Zhou, X., Zhang, H., & Zhang, G. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-4602 · Cited by 27 · see citing works
Ren, S., Zhou, R., Tang, Z., Song, Z., Li, N., Shi, X., Liu, Y., & Chu, Y. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111598 · Cited by 26 · see citing works
Ho, C.-H., Huang, J.-H., Sun, M.-S., Tzeng, I., Hsu, Y., & Kuo, C. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/6671129 · Cited by 26 · see citing works
Salem, H. A., Elsherbiny, N. M., Alzahrani, S., Alshareef, H. M., Elmageed, Z. Y. A., Ajwah, S. M., Hamdan, A. M., Abdou, Y. S., Galal, O., Azazy, M. K. A.-E. E., et al. (2022) · Pharmaceuticals · doi:10.3390/ph15081012 · Cited by 30 · see citing works
Okuda-Hanafusa, C., Uchio, R., Fuwa, A., Kawasaki, K., Muroyama, K., Yamamoto, Y., & Murosaki, S. (2019) · Food & Function · doi:10.1039/c9fo00336c · Cited by 26 · see citing works
Zhu, Y., Ling, Y., & Wang, X. (2020) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2020.1725039 · Cited by 26 · see citing works
Cano-Martı́nez, A., Bautista‐Pérez, R., Castrejón-Téllez, V., Carreón‐Torres, E., Pérez-Torres, I., Díaz‐Díaz, E., Flores‐Estrada, J., Guarner‐Lans, V., & Rubio-Ruiz, M. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168939 · Cited by 25 · see citing works
Das, S. R., & Choudhuri, D. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117560 · Cited by 25 · see citing works
Effect of Isoquercitrin on Free Fatty Acid-Induced Lipid Accumulation in HepG2 Cells
Kim, S. H., Yun, C., Kwon, D., Lee, Y., Kwak, J., & Jung, Y. (2023) · Molecules · doi:10.3390/molecules28031476 · Cited by 24 · see citing works
Sphingosine Kinase 1 Aggravates Liver Fibrosis by Mediating Macrophage Recruitment and Polarization
Ding, X., Zhang, X., Cao, J., Chen, S., Chen, Y., Yuan, K., Chen, B., Yang, G., Li, S., Yang, J., et al. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.101406 · Cited by 23 · see citing works
Hu, Q., Zhang, W., Wei, F., Huang, M., Shu, M., Song, D., Wen, J., Wang, J.-D., Nian, Q., Ma, X., et al. (2023) · Phytotherapy Research · doi:10.1002/ptr.8043 · Cited by 23 · see citing works
Medicinal Plants As Natural Polarizers of Macrophages: Phytochemicals and Pharmacological Effects
Davoodvandi, A., Sahebnasagh, R., Mardanshah, O., Asemi, Z., Nejati, M., Shahrzad, M. K., Mirzaei, H. R., & Mirzaei, H. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190829154934 · Cited by 24 · see citing works
Wu, H., Wu, L., Luo, L., Wu, Y., Zhang, Q., Li, H., & Zhang, B.-F. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113444 · Cited by 22 · see citing works
Zhang, L., Shi, C., Lan, Y., Zhang, X., Ji, X., Li, L., He, X., Tan, Y., Zhao, N., & Lu, C. C. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s542641 · Cited by 26 · see citing works
Self-citationSelective suppression of M1 macrophages is involved in zinc inhibition of liver fibrosis in mice
Xie, C., Wan, L., Li, C., Feng, Y., & Kang, Y. J. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108802 · Cited by 22 · see citing works
Zhou, X., Yi, L., Lang, H., Zhang, J., Zhang, Q., Yu, L., Zhu, J., & Mi, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.887263 · Cited by 23 · see citing works
Wang, C., Liu, Y., Gong, L., Xue, X., Fu, K., Ma, C., & Li, Y. (2023) · Inflammation · doi:10.1007/s10753-023-01826-1 · Cited by 22 · see citing works
Moringa oleifera Improves MAFLD by Inducing Epigenetic Modifications
Monraz-Méndez, C. A., Escutia-Gutiérrez, R., Rodríguez-Sanabria, J. S., Galicia‐Moreno, M., Monroy-Ramírez, H. C., Sánchez-Orozco, L. V., Garcia-Bañuelos, J. J., la Rosa-Bibiano, R. D., Santos, A., Armendáriz‐Borunda, J., et al. (2022) · Nutrients · doi:10.3390/nu14204225 · Cited by 21 · see citing works
Ince, E. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-05148-0 · Cited by 21 · see citing works
Sahu, R., Goswami, S., Sastry, G. N., & Rawal, R. K. (2023) · Chemistry & Biodiversity · doi:10.1002/cbdv.202201029 · Cited by 20 · see citing works
The potential of flavonoids in hepatic fibrosis: A comprehensive review
Wenbo, Z., Jianwei, H., Hua, L., Tang, L., Guijuan, C., & Mengfei, T. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155932 · Cited by 20 · see citing works
Katsaros, I., Sotiropoulou, M. G., Vailas, M. G., Papachristou, F., Papakyriakopoulou, P., Grigoriou, M. E., Kostomitsopoulos, N. G., Giatromanolaki, A. N., Valsami, G. N., Tsaroucha, A. K., et al. (2024) · Nutrients · doi:10.3390/nu16244282 · Cited by 19 · see citing works
Saminathan, M., Singh, K. P., Maity, M., Vineetha, S., Manjunathareddy, G. B., Dhama, K., Malik, Y. S., Ramakrishnan, M. A., Misri, J., & Gupta, V. K. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.01.007 · Cited by 19 · see citing works
Zhang, J.-B., Jin, H., Feng, X., Feng, S., Zhu, W., Nan, H.-M., & Yuan, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.984611 · Cited by 19 · see citing works
A review of edible plant-derived natural compounds for the therapy of liver fibrosis
Xu, W., Wang, L., Niu, Y., Mao, L., Du, X., Zhang, P., Li, Z., Li, H., & Li, N. (2022) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002483 · Cited by 19 · see citing works
Sato, S., Norikura, T., & Mukai, Y. (2019) · Food & Function · doi:10.1039/c9fo01134j · Cited by 19 · see citing works
Zhu, Y., Fan, S., Lu, Y., Yan, W., Tang, J., Yang, Y., Li, F., Chen, Q., Zheng, J., & Liu, X. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.03.001 · Cited by 19 · see citing works
Quercetin Reduces Hepatic Fibrogenesis by Inhibiting TGF-β/Smad3 Signaling Pathway in LX-2 Cell Line
Shakerian, E., Akbari, R., Mohammadtaghvaei, N., Gahrooie, M. M., & Afarin, R. (2021) · Jundishapur Journal of Natural Pharmaceutical Products · doi:10.5812/jjnpp.113484 · Cited by 17 · see citing works
Xu, D., Yuan, L., Meng, F., Lu, D., Che, M., Yang, Y., Liu, W., & Nan, Y. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1430768 · Cited by 17 · see citing works
Banik, S., Yamada, K., Sato, H., & Onoue, S. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00009 · Cited by 17 · see citing works
Ma, X., Hao, C., Yu, M., Zhang, Z., Huang, J., & Yang, W. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/7291434 · Cited by 16 · see citing works
Ahammad, G. S., & Kim, I. H. (2024) · Animals · doi:10.3390/ani14131918 · Cited by 16 · see citing works
Guo, Z., Zhang, J., Li, M., Xing, Z., Li, X., Qing, J., Zhang, Y., Zhu, L., Qi, M., & Zou, X. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1442071 · Cited by 15 · see citing works
Self-citationSalama, Y., Hassan, H. M., El-Gayar, A. M., & Abdel‐Rahman, N. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122349 · Cited by 15 · see citing works
Recent Progress in Nano-TCM Active Ingredient Co-Delivery Systems for Inflammation-Mediated Diseases
Sun, C., Chen, J., Bai, S., Liao, W., Chen, J., Guo, W., Zeng, L., & Yu, L. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s526731 · Cited by 14 · see citing works
Flavonoids as modulators of gut-liver axis: emerging therapeutic strategies for MAFLD
Hao, M., Wang, Z., Wang, L., Yimamu, A., Su, X., Zhang, M., Li, X., Zhang, Q., & Sun, Z. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1657751 · Cited by 15 · see citing works
Self-citationMechanisms of Xiaochaihu Decoction on Treating Hepatic Fibrosis Explored by Network Pharmacology
Qiang, R., Zhang, Y., & Wang, Y. (2022) · Disease Markers · doi:10.1155/2022/8925637 · Cited by 14 · see citing works
Xu, D., Bi, S., Li, J., Ma, S., Yu, Z., Wang, Y., Chen, H.-M., Zhan, J., Song, X., & Cai, Y. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202402056 · Cited by 14 · see citing works
Li, T., Fu, W., Li, X., Huo, Y., Ji, H., Liang, T., & Zhang, R. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c15494 · Cited by 14 · see citing works
Self-citationHerbal medicines for the liver: from bench to bedside
Vargas-Pozada, E. E., & Muriel, P. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001485 · Cited by 14 · see citing works
Zhao, S., Li, J., Xing, X., Chen, J., Zhou, Q., & Sun, J. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109876 · Cited by 13 · see citing works
Elhady, S. S., Goda, M. S., Mehanna, E. T., El-Sayed, N. M., Hazem, R. M., Elfaky, M. A., Almalki, A. J., Mohamed, M. S., & Abdelhameed, R. F. A. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116823 · Cited by 13 · see citing works
Ciceu, A., Fenyvesi, F., Hermenean, A. O., Ardelean, S., Dumitra, S., & Puticiu, M. I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179346 · Cited by 13 · see citing works
Use quercetin for pulmonary fibrosis: a preclinical systematic review and meta-analysis
Wu, X., Xiao, X., Su, Y., Zhang, Y., Li, G., Wang, F., Du, Q., & Yang, H. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01678-1 · Cited by 13 · see citing works
Kom, H., Nageshwar, M., Srilatha, K., & Karnati, P. R. (2019) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2019.90412 · Cited by 15 · see citing works
Ahmad, E., Jahangeer, M., Akhtar, Z. M., Aziz, T. A., Alharbi, M., Alshammari, A., Alasmari, A. F., & Bukhari, N. I. (2023) · Acta Biochimica Polonica · doi:10.18388/abp.2020_6772 · Cited by 12 · see citing works
Lead compounds with the potentials for the treatment of chronic liver diseases
Ezhilarasan, D. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817890-4.00012-3 · Cited by 12 · see citing works
Cheshmehnoor, P., Rabbani, S., & Haeri, A. (2023) · Nanomedicine · doi:10.2217/nnm-2022-0032 · Cited by 12 · see citing works
Oh, E.-J., Lee, J., Cho, S., Kim, S. W., Jo, K. W., Shin, W., Gwak, S. H., Ha, J., Jeon, S. Y., Park, J.-H., et al. (2023) · Molecular Pharmacology · doi:10.1124/molpharm.123.000675 · Cited by 12 · see citing works
Liu, L., Wang, B., Ma, Y., Sun, K., Wang, P., Li, M., Dong, J., Qin, M., Li, M., Wei, C., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1443667 · Cited by 11 · see citing works
A Genetically Engineered Biomimetic Nanodecoy for the Treatment of Liver Fibrosis
Du, Y., Ding, H., Chen, Y., Gao, B., Mao, Z., Wang, W., & Ding, Y. (2024) · Advanced Science · doi:10.1002/advs.202405026 · Cited by 11 · see citing works
Wu, Y., He, Q., Shang, M., Yin, Y.-X., Li, Y., Du, X., & Li, X.-R. (2021) · Parasites & Vectors · doi:10.1186/s13071-021-04663-z · Cited by 11 · see citing works
Self-citationQuercetin ameliorates acute lung injury in a rat model of hepatopulmonary syndrome
Nassef, N. A., Hamid, M. S. A.-E., Abusikkien, S. A., & Ahmed, A. I. (2022) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-022-03785-w · Cited by 11 · see citing works
Li, J., Tang, Y., Li, W., & Tu, Y. (2020) · Chemistry - A European Journal · doi:10.1002/chem.201905272 · Cited by 11 · see citing works
Macrophage-tregs crosstalk: the “hub” of the immune network in MASLD
Zhao, H., Wang, W., Zhu, P., & Shi, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1680878 · Cited by 10 · see citing works
Han, Q., Zhu, J., & Zhang, P. (2023) · Medicine · doi:10.1097/md.0000000000034353 · Cited by 10 · see citing works
Ashour, H., Rashed, L. A., Hassanein, R. T. M., Aboulhoda, B. E., Ebrahim, H. A., Elsayed, M. H., Elkordy, M. A., & Abdelwahed, O. M. (2022) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2022.2134423 · Cited by 9 · see citing works
Sharma, R., Majee, C., Mazumder, R., Padhi, S., Khan, F., & Pal, R. S. (2024) · Indian Journal of Pharmaceutical Education and Research · doi:10.5530/ijper.58.1s.4 · Cited by 9 · see citing works
Xiang, W., Yin, G., Liu, H., Wei, J., Yu, X., Xie, Y., Zhang, L., XueTang, Jiang, W., & Lu, N. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.129670 · Cited by 9 · see citing works
- Authors
- Li, X., Jin, Q., Yao, Q., Xu, B., Li, L., Zhang, S., & Tu, C.
- Affiliations
- Fudan University (CN)
- Corresponding author
- Zhang, Shuncai
- Tu, Chuantao
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2018-02-09
- Volume
- 9
- Pages
- 72-72
- ISSN
- 1663-9812 (ISSN-L)
- PMC
- PMC5819566
- OpenAlex
- W2793967975
- Cited by
- 171
- References
- 43
- Citations by year
- 2026: 16 · 2025: 21 · 2024: 24 · 2023: 23 · 2022: 19 · 2021: 26 · 2020: 25 · 2019: 14 · 2018: 2
- FWCI
- 10.50
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Frontiers in Pharmacology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (81170398)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Pharmacology › Flavonoids in Medical Research
- Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
- Keywords
- quercetin, liver fibrosis, liver inflammation, hepatic macrophages, M1 macrophage polarization, Notch1 signaling, hepatic stellate cell activation, carbon tetrachloride-induced liver injury, antifibrotic therapy, chronic liver disease, inflammatory cytokines, nitric oxide synthase 2, macrophage infiltration, flavonoids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review